Avita Medical | 1811094D - Current Liabilities



Avita Medical reported AUD20.16M in Current Liabilities for its fiscal semester ending in December of 2024.


Current Liabilities Change Date
Adcock Ingram Holdings ZAR 2.81B 279.84M Dec/2024
Celltrion KRW 3.4T 216.25B Mar/2025
Clinuvel Pharmaceuticals AUD 25.21M 4.17M Jun/2024
Cochlear AUD 626.1M 5.4M Dec/2024
CSL USD 6.07B 1.12B Dec/2024
Cspc Pharmaceutical CNY 9.63B 801.28M Dec/2024
Dianthus Therapeutics USD 20.09M 1.64M Jun/2025
Divis Laboratories Ltd 14.52B 1.61B Mar/2025
Kangmei Pharma CNY 5.75B 64.58M Jun/2025
Knight Therapeutics CAD 118.15M 12.32M Sep/2024
Laboratorios Farma EUR 186.51M 29.86M Jun/2025
Malin Corporation EUR 1000K 500K Dec/2024
Mayne Pharma AUD 313.94M 18.28M Jun/2024
Medical Developments International AUD 6.37M 3.17M Dec/2024
Nanosonics AUD 38.76M 6.53M Dec/2024
Neuren Pharmaceuticals AUD 45.76M 36.79M Dec/2024
Organigram Holdings CAD 107.28M 38.32M Jun/2025
Pacific Edge NZD 9.76M 1.33M Mar/2025
Paradigm Biopharmaceuticals AUD 1.08M 2.28M Dec/2024
Pharma Mar EUR 87.78M 8.29M Jun/2025
Polynovo AUD 23.25M 9.22M Jun/2024
PYC Therapeutics AUD 11.38M 2.27M Dec/2024
Qiagen NV USD 1.13B 611.37M Jun/2025
Ramsay Health Care AUD 3.72B 465.1M Dec/2024
ResMed USD 1.02B 167.16M Jun/2025
Sartorius EUR 1.55B 72.7M Jun/2025
Sino Biopharmaceutical CNY 19.56B 2.39B Dec/2024
Telix Pharmaceuticals AUD 330.91M 72.54M Dec/2024
Tilray USD 278.52M 15.02M Nov/2024
Zz Pientze Pharmaceu 3.2B 878.89M Jun/2025